9542 Federal Register / Vol. 72, No. 41 / Friday, March 2, 2007 / Notices 

released at the meeting. There also will 

be updates on the Committee’s draft 

report on pharmacogenomics and 

several Federal initiatives and activities. 

Time will be provided each day for 

public comments. The Committee 

would welcome hearing from anyone 

wishing to provide public comments on 

any issue related to genetics, health and 

society. Individuals who would like to 

provide public comment should notify 

the SACGHS Executive Secretary, Ms. 

Sarah Carr, by telephone at 301–496–

9838 or e-mail at sc112c@nih.gov. The 

SACGHS office is located at 6705 

Rockledge Drive, Suite 750, Bethesda, 

MD 20892. Anyone planning to attend 

the meeting, who is in need of special 

assistance, such as sign language 

interpretation or other reasonable 

accommodations, is also asked to 

contact the Executive Secretary. 

Under authority of 42 U.S.C. 217a, 

Section 222 of the Public Health Service 

Act, as amended, the Department of 

Health and Human Services established 

SACGHS to serve as a public forum for 

deliberations on the broad range of 

human health and societal issues raised 

by the development and use of genetic 

and genomic technologies and, as 

warranted, to provide advice on these 

views. The draft meeting agenda and 

other information about SACGHS, 

including information about access to 

the Web cast, will be available at the 

following Web site: http:// 

www4.od.nih.gov/oba/sacghs.htm. 

Dated: February 22, 2007. 

Anna Snouffer, 

Acting Director, NIH Office of Federal 

Advisory Committee Policy. 

[FR Doc. 07–965 Filed 3–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate proposals for 

support through the RAID program by 

making available to the research 

community, on a competitive basis, NCI 

new agent development contract 

resources for the preclinical 

development of drugs and biologics. 

The outcome of the evaluation will be 

a decision whether NCI should support 

the request and make available contract 

resources for support through the RAID 

program to the research community and 

NCI new agent development for the 

preclinical development of drugs and 

biologics. The research proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the 

proposed research projects, the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel; Rapid 

Access to Intervention Development. 

Date: March 20–21, 2007. 

Time: 1 p.m.–5 p.m. 

Agenda: To evaluate the Rapid Access to 

Intervention Development Portfolio. 

Place: National Institutes of Health, 

Executive Plaza North, Conference Room J, 

6130 Executive Boulevard, Rockville, MD 

20852. 

Contact Person: Phyllis G. Bryant, 

Executive Secretary, Program Analyst, 

Developmental Therapeutics Program, 

National Cancer Institute, NIH, 6130 

Executive Boulevard, Rm. 8022, Bethesda, 

MD 20892. (301) 496–8720. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: February 22, 2007 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–968 Filed 3–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

Board of Scientific Counselors for Basic 

Sciences National Cancer Institute. The 

meeting will be closed to the public as 

indicated below in accordance with the 

provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Cancer Institute, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Board of Scientific 

Counselors for Basic Sciences National 

Cancer Institute. 

Date: March 4–5, 2007. 

Time: March 4, 2007, 6 p.m. to 10:15 p.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: Double Tree Hotel, 8120 Wisconsin 

Avenue, Bethesda, MD 20814. 

Time: March 5, 2007, 8 a.m. to 10 a.m. 

Agenda: To review and evaluate personal 

qualifications and performance, and 

competence of individual investigators. 

Place: National Institutes of Health, 

National Cancer Institute, 9000 Rockville 

Pike, Building 31, Conference Room 6, 

Bethesda, MD 20892. 

Contact Person: Florence E. Farber, PhD, 

Executive Secretary, Office of the Director, 

National Cancer Institute, National Institutes 

of Health, 6116 Executive Boulevard, Room 

2115, Bethesda, MD 20892, 301–496–7628, 

ff6p@nih.gov. 

This notice is being published less than 15 

days prior to meeting due to scheduling 

conflicts. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: February 23, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–970 Filed 3–1–07; 8:45 am] 

BILLING CODE 4140–01–M 


pwalker on PROD1PC71 with NOTICES